Blood fat-regulating medicine composition
A technology for regulating blood lipids and compositions, which is applied in the field of pharmaceutical compositions for regulating blood lipids, and can solve the problems of high production cost, complicated preparation process and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] The weight ratio of the components of the pharmaceutical composition of the present invention is as follows:
[0026] Gypenosides powder 27 parts Monascus powder 225 parts
[0027] Gardenia 450 parts
[0028] With the above-mentioned pharmaceutical composition, according to the stated dosage, (1), decoct and concentrate, take Gardenia jasmine, add water and cold soak for one hour, decoct twice, each time for one hour, filter the decoction, combine the filtrate, reduce Concentrate under pressure to a relative density of 1.25 (60°C), release to obtain a concentrated solution; (2), refine, add ethanol to the concentrated solution to a concentration of 70%, let it stand overnight, take the supernatant, and wash the precipitate with 80% ethanol For the second time, merge into the supernatant, and recover ethanol from the supernatant under reduced pressure to obtain refined extract; (3), sterilize and granulate, dry the refined extract under reduced pressure, add Monascus po...
Embodiment 2
[0031] The weight ratio of the components of the pharmaceutical composition of the present invention is as follows:
[0032] Gypenosides powder 33 parts Monascus powder 275 parts
[0033] Gardenia 550 parts
[0034] The preparation method of the pharmaceutical capsule of the present invention is the same as in Example 1.
Embodiment 3
[0036] The weight ratio of the components of the pharmaceutical composition of the present invention is as follows:
[0037] Gypenosides powder 30 parts Monascus powder 250 parts
[0038] Gardenia 500 parts
[0039] The preparation method of the pharmaceutical capsule of the present invention is the same as in Example 1.
[0040] It has been proved by animal experiments that this medicinal composition can significantly reduce the content of cholesterol and triglyceride in serum, and has a significant effect on clearing BDL, which is the main substance causing vascular lipid deposition, and has a positive effect on "scavenger" high-density lipoprotein. Elevating effect, so as to "raise" and "decrease" blood lipids, and play a role in regulating blood lipids.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More